Heart surgery guideRequest a specialist assessment
Heart surgery guide/Samir Kapadia

Samir Kapadia · Decision guide

Samir Kapadia: TAVR and interventional cardiology

Catheter aortic-valve treatment with seven-year trial evidence · Cleveland, Ohio, United States

Research by Yevhenii Kozlov · Co-Founder of BookimedUpdated 8 October 2026Sources linked throughout

At a glance

Samir Kapadia is a Cleveland Clinic interventional cardiologist whose practice includes TAVR and other percutaneous valve treatments. His role is catheter therapy within a heart team; surgical valve replacement is performed by a cardiac surgeon.

A catheter specialist

His official profile names TAVR, percutaneous valve therapies and complex coronary interventions.

Sources: Samir Kapadia, MD

Seven-year randomized comparison

PARTNER 3 randomized 1,000 low-risk patients with severe symptomatic aortic stenosis and found no significant difference in its two primary composites at seven years.

Sources: Transcatheter or Surgical Aortic-Valve Replacement in Low-Risk Patients at 7 Years.

Durability remains time-bounded

The trial reported bioprosthetic valve failure of 6.9% after TAVR and 7.5% after surgery at seven years, not lifetime durability.

Sources: Transcatheter or Surgical Aortic-Valve Replacement in Low-Risk Patients at 7 Years.

Portrait of Samir KapadiaPortrait source ↗

interventional cardiologist

Samir Kapadia

Cleveland Clinic →

Interventional cardiologist; Chair, Department of Cardiovascular Medicine

Interventional cardiologist; Chair, Department of Cardiovascular Medicine · Cleveland, Ohio, United States.

Read the clinical or research source ↗
Request a specialist assessment

Your diagnosis, selected specialist and treatment priorities.

Benefits and limitations

Potential advantages

Trade-offs and limits

Procedure-specific research

Seven-year randomized comparison of TAVR and surgery

PARTNER 3 randomized 1,000 low-risk patients with severe symptomatic aortic stenosis. At seven years the report found no significant difference in its two primary composite endpoints involving death, stroke and rehospitalization.

How to interpret this: Selected trial population and a particular transcatheter platform; industry funded. It does not establish lifetime durability, suitability for every anatomy, or Kapadia-specific complication rates.

Sources: Transcatheter or Surgical Aortic-Valve Replacement in Low-Risk Patients at 7 Years.

Clinical programme

Cleveland Clinic →

Cleveland, Ohio, United States

Cleveland’s cardiac services bring together different expertise: Gillinov’s mitral/robotic work, Smedira’s myectomy practice, Kapadia’s catheter valve treatment and Unai’s endocarditis and redo reconstruction. Its published cohorts show why valve anatomy and supporting tissues can matter as much as the incision.

Sources: Surgical management of left ventricular outflow tract obstruction in a specialized hypertrophic obstructive cardiomyopathy center · Early results of robotically assisted mitral valve surgery: Analysis of the first 1000 cases · Samir Kapadia, MD · Shinya Unai, MD — cardiac surgery profile · Mitral and Tricuspid Valve Center · Robotically Assisted Mitral Valve Repair: Patient Applications Grow · Nicholas Smedira — current clinical profile · Transcatheter or Surgical Aortic-Valve Replacement in Low-Risk Patients at 7 Years. · The Hidden Burden of Native Aortic Valve Endocarditis: Reevaluating Diagnostic and Pathologic Challenges. · Mitral valve abscess: echocardiographic imaging, microbiology, management, and outcomes.

Explore the programme and other specialists →

Continue your guide

Related heart surgery guides

Cleveland ClinicSpecialistsCompare surgeon expertiseHeart valves

Turn information into your next step.

Free Bookimed support. Compare options before deciding.

Request a specialist assessment
Request a specialist assessment

Your diagnosis, selected specialist and treatment priorities.